Product analysis
Boron 6 mg offers a low-cost, single-ingredient serving for people interested in boron and mineral metabolism. A lasting testosterone benefit remains uncertain.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality100
The branded glycine-based boron source is clearly identified. Its favorable form finding supports preparation comparison without establishing lasting hormone effects.
Ingredient Transparency100
The boron amount and source are both stated. That makes it easier to compare servings without interpreting an unspecified blend.
Value For Money100
The boron contribution is inexpensive for the amount supplied. The single-ingredient formula makes that value comparison easy to interpret.
Customer Satisfaction91
Customer ratings are very positive across a large feedback pool. That describes satisfaction without confirming mineral or hormone outcomes.
Product Focus72
The formula stays focused on boron, whose proposed mineral-metabolism role has limited support for broad everyday benefits. Boron is not established as an essential human nutrient, and sustained testosterone effects remain uncertain.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $0.07
- Customer rating
- 4.8 · 6,200 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Boron (Albion Bororganic Glycine) | 6 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
Boron Form & Bioavailability
Trademarked & High-Purity Sources
Dose, Safety & Label Transparency100
Elemental Dose Transparency
Dosage Efficacy & Safety Margin
Value100
Price per 3mg Elemental Boron
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effects of boron supplementation on the severity and duration of pain in primary dysmenorrhea.
- Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies.
- The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis.
- Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
- Effects of Calcium Fructoborate on Levels of C-Reactive Protein, Total Cholesterol, Low-Density Lipoprotein, Triglycerides, IL-1β, IL-6, and MCP-1: a Double-blind, Placebo-controlled Clinical Study
- Biochemical and physiologic consequences of boron deprivation in humans.
- Plasma boron and the effects of boron supplementation in males.
- Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines